Solventum Corporation (NYSE:SOLV) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Solventum Corporation (NYSE:SOLV) have earned an average rating of “Moderate Buy” from the twelve brokerages that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $93.70.

A number of brokerages recently weighed in on SOLV. Mizuho set a $100.00 price objective on shares of Solventum and gave the company an “outperform” rating in a research report on Tuesday, January 20th. Zacks Research cut shares of Solventum from a “strong-buy” rating to a “hold” rating in a report on Monday, December 1st. BTIG Research restated a “buy” rating and issued a $100.00 target price on shares of Solventum in a research note on Friday, February 27th. Piper Sandler reaffirmed an “overweight” rating on shares of Solventum in a report on Wednesday, December 17th. Finally, Stifel Nicolaus increased their price target on Solventum from $88.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, January 7th.

Institutional Investors Weigh In On Solventum

Large investors have recently added to or reduced their stakes in the stock. Hilltop National Bank boosted its holdings in shares of Solventum by 71.3% during the fourth quarter. Hilltop National Bank now owns 310 shares of the company’s stock valued at $25,000 after acquiring an additional 129 shares during the period. CrossGen Wealth LLC acquired a new stake in shares of Solventum in the 4th quarter worth about $25,000. Measured Wealth Private Client Group LLC bought a new stake in Solventum in the 3rd quarter valued at about $25,000. JNBA Financial Advisors lifted its position in Solventum by 205.4% in the 4th quarter. JNBA Financial Advisors now owns 339 shares of the company’s stock valued at $27,000 after purchasing an additional 228 shares during the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in Solventum during the 2nd quarter valued at about $28,000.

Solventum Stock Performance

Solventum stock opened at $67.57 on Wednesday. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.23 and a quick ratio of 0.89. Solventum has a 12 month low of $60.70 and a 12 month high of $88.20. The company has a fifty day moving average price of $77.14 and a two-hundred day moving average price of $76.13. The company has a market cap of $11.72 billion, a PE ratio of 7.62, a P/E/G ratio of 1.12 and a beta of 0.40.

Solventum (NYSE:SOLV) last issued its earnings results on Thursday, February 26th. The company reported $1.57 earnings per share for the quarter, topping analysts’ consensus estimates of $1.50 by $0.07. Solventum had a net margin of 18.69% and a return on equity of 25.26%. The company had revenue of $2 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same period in the prior year, the company earned $1.41 earnings per share. The firm’s revenue was down 3.7% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 6.400-6.600 EPS. Research analysts expect that Solventum will post 6.58 earnings per share for the current year.

Solventum declared that its board has initiated a share buyback plan on Thursday, November 20th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 7.5% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.